Recent Finacing
Recent Raise
Coronado Biosciences develops immunotherapies: CNDO-201, an oral immunomodulator that modulates T cells and cytokines for IBD and MS, and CNDO-109, an NK-cell priming biologic for blood and solid tumors.
Recent Investors
Total Raised
Funding rounds
Investor